Comment: QM107 is a synthetic short peptide that mimics the CD148-binding domain of human syndecan 2 (
SDC2;
P34741). It was designed to activate CD148 phosphatase activity as a mechanism to inhibit pro-angiogenic signalling as a novel treatment for neovascular age-related macular degeneration.
